-
A glimpse into the clinical trials of the future. Join the Discussion
#mePharma pic.twitter.com/rmAKiSO0Sh
-
Striving for excellence in clinical monitoring
@Novartis#mePharma pic.twitter.com/JQtlCRgc97
-
Thank you
@marcusevans for hosting another wonderful Evolution Summit last week in San Diego! We had a great time connecting with Industry leaders and look forward to meeting again in Boston!#mePharma#PharmaOut -
Join CTTI Executive Director
@PamelaTenaerts Monday at#EvolutionSummit, where she will discuss bridging the gap between the pharma industry and digitization#mePharma pic.twitter.com/GLzVjk0ZqQ
-
-
How can stakeholders in
#clinicalresearch work to bring digitization to the pharma industry? Executive Director@PamelaTenaerts will be sharing CTTI’s Mobile Clinical Trials work at#EvolutionSummit TODAY!#mePharma pic.twitter.com/ARZ942tqFW
-
Shaheen Limbada presenting live at the Evolution Summit Boston today on “How to Manage E6(R2) Compliance as it Relates to Risk? A Guide to Selecting and Presenting Key Risk Indicators (KRIs) to Ensure R2 Compliance”.
#mePharma http://bit.ly/2OoUgz2 pic.twitter.com/7lRy5beAnb
-
Selecting the right EDC System for a clinical program requires that you consider the short-term and long-term goals of the entire clinical program, not just a single study. Read the Q&A to learn more.
#mePharma http://bit.ly/34Zbf1A pic.twitter.com/a02YddqQXc
-
Counting down the days until our Evolution Summit. Dr Jonathan Sheffield, CEO at NIHR Clinical Research Network is one of our confirmed speakers.
#mePharma More info: https://bit.ly/2lSn1K1 pic.twitter.com/EP0fr6PvH6
-
Thanks
@marcusevans#mepharma for the opportunity to share these learnings. pic.twitter.com/RF7tW4Zt1e
-
Jenny Wakefield, Director, Senior Clinical Trial Head at Incyte, will be part of our panel discussion on what it takes to accelerate study start-up. Head to the Evolution Summit page for details: https://bit.ly/3aPVvla
#mePharma#ClinicalTrials#Evolutionpic.twitter.com/ChGl77Dmoi
-
The primary objective of the 19th Evolution Summit is to explore the key aspects and issues related to clinical trial best practices and their application as business drivers for innovation and growth.
#mePharma Find out more here: https://lnkd.in/eWuX5Xp pic.twitter.com/icOLsT5hPw
-
We are proud to announce our partnership with renowned global industry publications, magazines, news providers and associations in making the Evolution Summit your ultimate event every year.
#mePharma Find out more: https://bit.ly/2qmeK2Y pic.twitter.com/zOKn6y51fB
-
Check out the November issue of
@IntClinTrials - one of our Official Media Partners for the upcoming Evolution Summit next March in California. Learn more here: https://bit.ly/36BojLt#mePharma https://twitter.com/IntClinTrials/status/1197092288775806977 …
-
Headed to
#EvolutionSummit to learn about best practices and new approaches for#clinicaltrials? CTTI Executive Director@PamelaTenaerts will be sharing recommendations for digital success Monday#mePharma pic.twitter.com/ut2KaLRTiC
-
Emily Roberts-Thomson, VP, Clinical Operations at Acerta Pharma will be giving her insights on 'Settling with the Right CRO and Augmenting the Relationship' at the Evolution Summit --->https://bit.ly/3aPVvla
#mePharma#ClinicalTrials#Evolutionpic.twitter.com/rXnAyRUSJj
-
Joining us as a presenter at the Evolution Summit this March is Dmitri Lissin, Chief Medical Officer at
#Scilex Pharmaceuticals.#mePharma#Evolution#Clinical Trials Find out more: https://bit.ly/3aPVvla pic.twitter.com/b118xZnnCO
-
Craig Ostroff, Vice President & Head, Cardiovascular & Metabolic Disease, Retinal Gene Therapy Areas, Global Regulatory Affairs at Janssen, will be presenting at the Evolution Summit this March – Be with the leaders! https://bit.ly/37vCnXM
#mePharma#Evolution#clinicaltrialspic.twitter.com/45TQfDXzcH
-
Excited to welcome Chad Swanson, Executive Director, Neurology Business Group at Eisai, Inc., as a speaker at the Evolution Summit this March 2-4 in Napa, CA. Further details here: https://bit.ly/37vCnXM
#mePharma#Evolution#clinicaltrialspic.twitter.com/i8Zs6wwPGq
Čini se da učitavanje traje već neko vrijeme.
Twitter je možda preopterećen ili ima kratkotrajnih poteškoća u radu. Pokušajte ponovno ili potražite dodatne informacije u odjeljku Status Twittera.